https://www.marketscreener.com/quote/stock/BAUSCH-HEALTH-COMPANIES-I-1409292/news/Valeant-Pharmaceuticals-Intl-And-EyeGate-Enter-Into-Licensing-Agreement-For-EGP-437-Combination-Pr-23913761/?utm_source=telegram&utm_medium=social&utm_campaign=share